Rated 4.00 out of 5
Aduhelm represents a significant step forward in the treatment of Alzheimer’s disease, with its advanced effects and benefits making it an exciting development in the field of Alzheimer’s research.
The drug offers hope to millions of people worldwide suffering from Alzheimer’s disease,
Rated 5.00 out of 5
Amondys 45 (casimersen) is an FDA-approved medication that can potentially improve the quality of life of DMD patients who have a specific mutation in exon 45 of the dystrophin gene.
Amondys 45 works by inducing exon skipping and promoting the production of truncated dystrophin, which can partially restore muscle function in affected individuals.
Fleqsuvy (baclofen) is a medication used for the treatment of people with spasticity from multiple sclerosis (MS) or people with certain injuries to the spine.
Kesimpta (ofatumumab) is a highly effective and convenient treatment option for patients with relapsing forms of MS.
Its unique mechanism of action, which targets and depletes B cells from the body,
– $1,753.62 $11,208.31
Mavenclad is a new and promising treatment option for relapsing forms of multiple sclerosis.
The drug has several advantages, including its advanced effects on reducing relapse frequency, delaying relapse time, slowing down MS progression, and having a unique dosing regimen.
1 tablet of 10 mg
4 tablets of 10 mg
6 tablets of 10 mg
Rated 5.00 out of 5
– $454.39 $1,050.00
Neupro patch is a promising advancement in the treatment of Parkinson’s disease.
Its continuous and convenient delivery of medication, along with its ability to improve both motor and non-motor symptoms, makes it a valuable option for patients and healthcare professionals alike.
Ocrevus (ocrelizumab) is a biologic drug that has revolutionized the treatment of MS.
Its ability to selectively target and eliminate B cells has shown impressive efficacy in slowing down the progression of this debilitating disease. 1 vial of 300 mg/mL
– $1,030.22 $2,050.00
Ponvory (ponesimod) is an advanced medication that offers a promising treatment option for relapsing MS.
It effectively suppresses inflammatory immune cells and promotes neuroprotection, leading to a reduction in relapse rates and potential neuroprotective benefits.
Qulipta (atogepant) is a prescription medicine used for the prevention of episodic migraine in adults.
Tecfidera (dimethyl fumarate) is an oral medication that is used to treat multiple sclerosis in adults.
It works by reducing inflammation in the central nervous system, which can help to reduce MS relapses and slow down the progression of disability. 56 capsules of 240 mg
Vyvgart (efgartigimod alfa-fcab) is a medication used to treat adults with generalized Myasthenia Gravis (gMG).
Wakix represents a significant advance in the treatment of narcolepsy and other sleep disorders.
Its unique mechanism of action, low risk of side effects, and ability to treat both excessive daytime sleepiness and cataplexy make it a valuable treatment option for people with narcolepsy who have not responded well to other treatments.